Mabletown, GA — September 1, 2026 — Embarr Downs, Inc. (OTC: EMBR) today announced a strategic roadmap for the year ahead as the Company establishes itself as a growth-focused operating business following its return to current information status on OTC Markets.
Company enters new phase under new CEO Mark Jones with two revenue-generating acquisitions closed and a defined path toward continuing compliance and its rollup campaign.
"This is the moment Embarr becomes a real company again in the eyes of the market," said Mark Jones, Chief Executive Officer of Embarr Downs. "We’ve done the quiet work — closing acquisitions, updating our disclosures, and putting the pieces in place. Now we’re laying out the path we intend to walk, and we intend to walk it in the open."
Where the Company stands today
Embarr Downs has completed two acquisitions of revenue-generating businesses representing approximately $0.39 million in combined revenue for the three months ended May 31, 2026 (unaudited). The Company has uploaded current financial information to its OTC Markets profile, transitioned to new leadership under CEO Mark Jones, and is actively providing updates about its corporate profile and activities.
The roadmap ahead
The Company’s near- and longer-term priorities include:
Pursuing removal of shell-company tag. Working through the requirements to have the Company reclassified as an operating business.
Growing revenue through disciplined acquisitions. Continuing due diligence on additional revenue-generating businesses that fit the Company’s growth thesis and build on its current base.
Strengthening the capital structure. Evaluating measures intended to support a cleaner, more efficient share structure over time.
Moving toward audited financials. Engaging the process required to produce audited financial statements as the Company matures.
Building a foundation for future uplisting to OTCQB or better. Developing the operational and financial profile that could, in time, position Embarr to qualify for a higher more prestigious exchange, subject to meeting all applicable listing requirements.
"We’re not starting from zero — we’re starting from real revenue and real momentum," Jones added. "Our vision is significant, but we’re going to earn it milestone by milestone and let our filings do the talking. Thank you to every shareholder who has stayed with us. The building starts now."
About Embarr Downs, Inc.
Embarr Downs, Inc. (OTC: EMBR) is a growth-focused Regenerative Health and Biotechnology company pursuing value creation through strategic acquisitions and disciplined operational development.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements reflect the Company’s current expectations and are subject to risks and uncertainties that could cause actual results to differ materially. Financial figures described as annualized revenue are unaudited and subject to change upon completion of audited financial statements. Words such as "intends," "plans," "expects," and similar expressions identify forward-looking statements. There is no assurance the Company will achieve any milestone described, including removal of shell status, production of audited financials, any change to its capital structure, or any future exchange listing. The Company undertakes no obligation to update these statements except as required by law. Investors should not place undue reliance on forward-looking statements and should review the Company’s disclosures on OTC Markets.